Trial Site Detail
Drug: |
Imatinib + BYL719 |
|||
|---|---|---|---|---|
Trial: |
A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
OHSU Knight Cancer Institute South Waterfront3485 S. Bond Avenue |
Principal Investigator: |
Michael Mauro |
|---|---|
Contact: |
Dan Hansen 503-346-0792 hansedan@ohsu.edu |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
OHSU Knight Cancer Institute South Waterfront Website: |
https://cancertrials.ohsu.edu/studies/?term~sc_paths=cancer-types_gastrointestinal-stromal-tumors |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.